Efficacy and safety of CetuGEX in recurrent/metastatic squamous cell carcinoma of the head and neck (RM-NSCC): Results from the randomized phase II RESGEX study.

被引：4
|
作者：
Keilholz, Ulrich
Kawecki, Andrzej
Dietz, Andreas
Zurawski, Bogdan
Schenker, Michael
Kukielka-Budny, Bozena
Schafhausen, Philippe
Mihailov, Anca C.
Ochenduszko, Sebastian
Imarisio, Ilaria
Mihutiu, Simona
Oprean, Cristina-Marinela
Folprecht, Gunnar
Turcu, Alina
Rottey, Sylvie
Debourdeau, Philippe
Lavernia, Javier
Dietrich, Bruno
Zurlo, Alfredo
Fayette, Jerome
机构：
[1] Charite Comprehens Canc Ctr, Berlin, Germany
[2] M Sklodowska Curie Mem Inst, Canc Ctr, Warsaw, Poland
[3] Univ Leipzig, Leipzig, Germany
[4] F Lukaszczyk Oncol Ctr, Bydgoszcz, Poland
[5] S C Centrul Oncol, Policlin Sf Nectarie, Craiova, Romania
[6] Ctr Oncol, Lublin, Poland
[7] Univ Hamburg Eppendorf, Hamburg, Germany
[8] Univ Hosp Cluj, Cluj Napoca, Romania
[9] Krakow Univ Hosp Oncol Clin, Krakow, Poland
[10] IRCCS San Matteo Univ Hosp Fdn, Dept Med Oncol, Pavia, Italy
[11] Emergency Clin Hosp Oradea, Oradea, Bihor, Romania
[12] ONCOMED SRL, Timisoara, Romania
[13] Univ Hosp Carl Gustav Carus, Dresden, Germany
[14] SPITAL LOTUS SRL, Ploiesti, Romania
[15] Ghent Univ Hosp, Heymans Inst Pharmacol, Ghent, Belgium
[16] Inst Sainte Catherine, Avignon, France
[17] FIVO, Valencia, Spain
[18] Glycotope GmbH, Berlin, Germany
[19] Ctr Leon Berard, Med Oncol, Lyon, France
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 05期
关键词：
D O I：
10.1200/JCO.2018.36.5_suppl.59
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
59
引用
收藏
页数：2
相关论文
共 50 条
  • [31] A phase I study of avelumab, palbociclib, and cetuximab (APC) in recurrent or metastatic head and neck squamous cell carcinoma (RM HNSCC).
    Gold, Kathryn A.
    Sacco, Assuntina
    Bykowski, Julie
    Daniels, Gregory
    Pittman, Emily
    Messer, Karen
    Chen, Ruifeng
    Cohen, Ezra
    CANCER RESEARCH, 2021, 81 (13)
  • [32] Efficacy and safety of cisplatin and weekly docetaxel in patients with recurrent or metastatic squamous cell carcinoma of the head and neck
    Kim, Moon Jin
    Kim, Sung Min
    Jung, Hyun Ae
    Hong, Jung Yong
    Chang, Won Jin
    Choi, Moon Ki
    Kim, Hye Soak
    Sun, Jong-Mu
    Park, Keunchil
    Ahn, Myung-Ju
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2019, 34 (05): : 1107 - 1115
  • [33] Efficacy and safety of vinorelbine in heavily pretreated recurrent/metastatic head and neck squamous cell carcinoma patients
    Barth, Claire
    Naveau, Louise
    Touboul, Emmanuel
    Perie, Sophie
    Bamogho, Edith
    Haberer-Guillerm, Sophie
    Schlienger, Michel
    St Guily, Jean Lacau
    Huguet, Florence
    ANTI-CANCER DRUGS, 2016, 27 (04) : 349 - 352
  • [34] Safety and efficacy of durvalumab in patients with head and neck squamous cell carcinoma: results from a phase I/II expansion cohort
    Segal, Neil H.
    Ou, Sai-Hong, I
    Balmanoukian, Ani
    Fury, Matthew G.
    Massarelli, Etiuinia
    Brahmer, Julie R.
    Weiss, Jared
    Schoffski, Patrick
    Antonia, Scott J.
    Massard, Christophe
    Zandberg, Dan P.
    Khleif, Samir N.
    Xiao, Feng
    Rebelatto, Marlon C.
    Steele, Keith E.
    Robbins, Paul B.
    Angra, Natasha
    Song, Xuyang
    Abdullah, Shaad
    Butler, Marcus
    EUROPEAN JOURNAL OF CANCER, 2019, 109 : 154 - 161
  • [35] Pembrolizumab for recurrent/metastatic cutaneous squamous cell carcinoma (cSCC): Efficacy and safety results from the phase II KEYNOTE-629 study
    Grob, J. J.
    Gonzalez Mendoza, R.
    Basset-Seguin, N.
    Vornicova, O.
    Schachter, J.
    Joshi, A.
    Meyer, N.
    Grange, F.
    Piulats, J. M.
    Bauman, J.
    Zhang, P.
    Gumuscu, B.
    Swaby, R. F.
    Hughes, B. G. M.
    ANNALS OF ONCOLOGY, 2019, 30 : 908 - 908
  • [36] Carboplatin (C), cetuximab (Cet), and everolimus (E) in recurrent or metastatic squamous cell carcinoma of the head and neck (RMSCCHN). Results of a phase Ib study.
    Saba, Nabil F.
    Kono, Scott A.
    Mendel, Jennifer Robin
    Hurwitz, Selwyn J.
    Owonikoko, Taofeek Kunle
    Lewis, Colleen Margaret
    Harvey, Donald
    Rogerio, Jaqueline Willemann
    Chen, Zhengjia
    Wadsworth, Trad
    El-Deiry, Mark
    Chen, Amy Y.
    Higgins, Kristin
    Ramalingam, Suresh S.
    Beitler, Jonathan Jay
    Shin, Dong M.
    Khuri, Fadlo Raja
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [37] Cisplatin/UFUR/irinotecan triple combination therapy for recurrent/metastatic head and neck squamous cell carcinoma: A phase I/II clinical study.
    Chen, San-Chi
    Chang, Peter
    Yang, Muh-Hwa
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [38] A phase II study of docetaxel in patients with metastatic squamous cell carcinoma of the head and neck
    Couteau, C
    Chouaki, N
    Leyvraz, S
    Oulid-Aissa, D
    Lebecq, A
    Domenge, C
    Groult, V
    Bordessoule, S
    Janot, F
    De Forni, M
    Armand, JP
    BRITISH JOURNAL OF CANCER, 1999, 81 (03) : 457 - 462
  • [39] A phase II study of docetaxel in patients with metastatic squamous cell carcinoma of the head and neck
    C Couteau
    N Chouaki
    S Leyvraz
    D Oulid-Aissa
    A Lebecq
    C Domenge
    V Groult
    S Bordessoule
    F Janot
    M De Forni
    J-P Armand
    British Journal of Cancer, 1999, 81 : 457 - 462
  • [40] Phase II trial of sorafenib in patients with recurrent or metastatic squamous cell carcinoma of the head and neck or nasopharyngeal carcinoma
    Elser, Christine
    Siu, Lillian L.
    Winquist, Eric
    Agulnik, Mark
    Pond, Gregory R.
    Chin, Soo F.
    Francis, Peggy
    Cheiken, Robin
    Elting, James
    McNabola, Angela
    Wilkie, Dean
    Petrenciuc, Oana
    Chen, Eric X.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (24) : 3766 - 3773
12345